CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- RW Other RW
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- EFFECT Other Notice of Effectiveness
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 424B3 Offering Prospectus
- 15-12G Other 15-12G
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- S-8 POS Other Post-effective Amendment
- POS AM Other Post-effective Amendment for Registration Statement
- 25 Other Notification of Removal from Listing
- 8-K Event Delisting notice · Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 8-K Event Delisting notice
- 8-K Event Delisting notice
- 8-K Event Executive or director change
- 4 Open-market sale Chief Financial Officer sold 96,000 shares at $0.01 ($950)
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Operating Officer sold 207,000 shares at $0.01 ($2,091)
- 144 Insider Sale of Securities
Page 1 of 41 · 808 filings